WallStSmart

Colgate-Palmolive Company (CL)vsKenvue Inc. (KVUE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Colgate-Palmolive Company generates 37% more annual revenue ($21.05B vs $15.41B). KVUE leads profitability with a 10.8% profit margin vs 9.7%. KVUE appears more attractively valued with a PEG of 1.42. KVUE earns a higher WallStSmart Score of 60/100 (C).

CL

Buy

54

out of 100

Grade: C-

Growth: 3.3Profit: 8.5Value: 4.7Quality: 5.5
Piotroski: 4/9Altman Z: 4.21

KVUE

Buy

60

out of 100

Grade: C

Growth: 4.7Profit: 7.0Value: 4.7Quality: 5.0
Piotroski: 4/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLUndervalued (+11.6%)

Margin of Safety

+11.6%

Fair Value

$99.21

Current Price

$87.47

$11.74 discount

UndervaluedFair: $99.21Overvalued
KVUESignificantly Overvalued (-86.7%)

Margin of Safety

-86.7%

Fair Value

$9.93

Current Price

$17.81

$7.88 premium

UndervaluedFair: $9.93Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CL4 strengths · Avg: 9.3/10
Return on EquityProfitability
863.1%10/10

Every $100 of equity generates 863 in profit

Altman Z-ScoreHealth
4.2110/10

Safe zone — low bankruptcy risk

Market CapQuality
$69.19B9/10

Large-cap with strong market position

Operating MarginProfitability
21.0%8/10

Strong operational efficiency at 21.0%

KVUE0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CL4 concerns · Avg: 3.5/10
PEG RatioValuation
1.604/10

Expensive relative to growth rate

P/E RatioValuation
34.6x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
4.9%4/10

4.9% revenue growth

Price/BookValuation
291.6x2/10

Trading at 291.6x book value

KVUE2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.0%4/10

3.0% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Altman Z-Score, Market Cap.

Bull Case : KVUE

PEG of 1.42 suggests the stock is reasonably priced for its growth.

Bear Case : CL

The primary concerns for CL are PEG Ratio, P/E Ratio, Revenue Growth. Debt-to-equity of 33.29 is elevated, increasing financial risk.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Altman Z-Score.

Key Dynamics to Monitor

KVUE carries more volatility with a beta of 0.43 — expect wider price swings.

CL is growing revenue faster at 4.9% — sustainability is the question.

CL generates stronger free cash flow (867M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KVUE scores higher overall (60/100 vs 54/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Want to dig deeper into these stocks?